Inhibikase Therapeutics Inc (NAS:IKT)
$ 2.47 +0.060 (+2.49%) Market Cap: 387.87 Mil Enterprise Value: 300.24 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 36/100